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Recognition that a biochemically familiar enzyme called
(in homogenate terms) soluble guanylyl cyclase (GC),
serves as the major physiological receptor for NO imme-
diately raises a host of questions concerning how this
receptor transduces NO signals in the many different cells
in which it is found. Simply calling it a receptor (which it
is) is helpful in bringing into play a wealth of theoretical
and practical knowledge built up over decades to describe
and understand the principles of biological signalling
mechanisms. Viewed in this context, much of the most
basic information about the operation of GC-coupled NO
receptors was missing or incoherent. During the last few
years, we and others have tried to rectify this situation.
Devising methods for supplying NO in known, constant
concentrations [1,2] was a prerequisite for carrying out
meaningful experiments. Measurement of the potency of
NO for activating GC and of the rates of activation and
deactivation has now permitted the introduction of a sim-
ple but realistic kinetic model [3]. The receptors in cells
can detect very brief NO signals (millisecond range)
because they activate and deactivate with subsecond
kinetics, and they can also detect very low NO concentra-
tions (subnanomolar) There are, however, a number of
important differences in the way that the receptors behave
in cells versus cell-free preparations. For example, in
homogenates or with the purified protein, NO is about
10-fold more potent as an agonist than it is in intact cells
and, unlike in cells, NO-evoked GC activity does not
desensitize. The possible role of a number of endogenous
factors in shaping NO-evoked GC activity in cells will be
discussed.
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